載入...
IGF and mTOR pathway expression and in vitro effects of linsitinib and mTOR inhibitors in adrenocortical cancer
PURPOSE: The IGF and mTOR-pathways are considered as potential targets for therapy in patients with adrenocortical carcinoma (ACC). This study aims to describe the IGF pathway in ACC and to explore the response to the combined treatment with the IGF1R/IR inhibitor linsitinib, and mTOR inhibitors (si...
Na minha lista:
| 發表在: | Endocrine |
|---|---|
| Main Authors: | , , , , , , , , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Springer US
2019
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6551351/ https://ncbi.nlm.nih.gov/pubmed/30838516 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s12020-019-01869-1 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|